A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic.

Dorna KheirabadiFatemeh HaddadRazieh Sadat Mousavi-Roknabadi Mohammad RezaeisadrabadiHamidreza DehghanAylar Fazlzadeh

Published in: Journal of medical virology (2021)

Currently, remdesivir and favipiravir are advantageous drugs that should be administered in the early phases. Their side effects are not well known and need to be found in the following research projects. Steroids and tocilizumab have been considered beneficial in the cytokine storm phase.

Keyphrases

sars cov
systematic review
respiratory syndrome coronavirus
rheumatoid arthritis
coronavirus disease
quality improvement
juvenile idiopathic arthritis
rheumatoid arthritis patients
meta analyses